You could very well be right.
My only point was that in the example I wrote of (you know, the one I had sone skin in and knew a bit about, which is the only reason I made the mistake of writing here : ) ) was bought out for a premium of 72% to the share price. And that share price gave it a market value of $US 1.5 billion. That was a good gain when compared to the share price only a month before.
Is that better? I thought that drug was an example of an old chemo made new, and thought it would be of interest. I am sorry I misread the room.
What I should have said was RAC $1000000000 a share F@ck yea!!!!!!
Now can we all sing the company song? Hunter you lead us off....
Speculative M&A Transaction Analysis, page-845
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.065(4.05%) |
Mkt cap ! $262.4M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.62 | $1.51 | $261.3K | 168.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2000 | 1 |
View Market Depth
| Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |